Found 12 hits for monomerid = 50104705 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Matrix metalloproteinase-12 (MMP12)
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| 410 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Universität Bielefeld
Curated by ChEMBL
| Assay Description In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-12 |
J Med Chem 44: 3231-43 (2001)
BindingDB Entry DOI: 10.7270/Q2RN3758 |
More data for this Ligand-Target Pair | |
Matrix metalloproteinase-12 (MMP12)
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 410 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Athens
Curated by ChEMBL
| Assay Description Inhibition of MMP12 |
Bioorg Med Chem 16: 8781-94 (2008)
Article DOI: 10.1016/j.bmc.2008.08.058 BindingDB Entry DOI: 10.7270/Q2JD4WM2 |
More data for this Ligand-Target Pair | |
Matrix metalloproteinase-14 (MMP14)
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 3.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Athens
Curated by ChEMBL
| Assay Description Inhibition of MMP14 |
Bioorg Med Chem 16: 8781-94 (2008)
Article DOI: 10.1016/j.bmc.2008.08.058 BindingDB Entry DOI: 10.7270/Q2JD4WM2 |
More data for this Ligand-Target Pair | |
Matrix metalloproteinase-14 (MMP14)
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| 3.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Universität Bielefeld
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against the catalytic domain of human matrix metalloprotease-14 |
J Med Chem 44: 3231-43 (2001)
BindingDB Entry DOI: 10.7270/Q2RN3758 |
More data for this Ligand-Target Pair | |
72 kDa type IV collagenase
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Universität Bielefeld
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against the catalytic domain of the human matrix metalloprotease-2 |
J Med Chem 44: 3231-43 (2001)
BindingDB Entry DOI: 10.7270/Q2RN3758 |
More data for this Ligand-Target Pair | |
Collagenase 3
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Athens
Curated by ChEMBL
| Assay Description Inhibition of MMP13 |
Bioorg Med Chem 16: 8781-94 (2008)
Article DOI: 10.1016/j.bmc.2008.08.058 BindingDB Entry DOI: 10.7270/Q2JD4WM2 |
More data for this Ligand-Target Pair | |
Neutrophil collagenase
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Athens
Curated by ChEMBL
| Assay Description Inhibition of MMP8 |
Bioorg Med Chem 16: 8781-94 (2008)
Article DOI: 10.1016/j.bmc.2008.08.058 BindingDB Entry DOI: 10.7270/Q2JD4WM2 |
More data for this Ligand-Target Pair | |
72 kDa type IV collagenase
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Athens
Curated by ChEMBL
| Assay Description Inhibition of MMP2 |
Bioorg Med Chem 16: 8781-94 (2008)
Article DOI: 10.1016/j.bmc.2008.08.058 BindingDB Entry DOI: 10.7270/Q2JD4WM2 |
More data for this Ligand-Target Pair | |
Collagenase 3
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Universität Bielefeld
Curated by ChEMBL
| Assay Description In Vitro inhibitory activity against the catalytic domain of the matrix metalloprotease-13 |
J Med Chem 44: 3231-43 (2001)
BindingDB Entry DOI: 10.7270/Q2RN3758 |
More data for this Ligand-Target Pair | |
Matrix metalloproteinase-9
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
University of Athens
Curated by ChEMBL
| Assay Description Inhibition of MMP9 |
Bioorg Med Chem 16: 8781-94 (2008)
Article DOI: 10.1016/j.bmc.2008.08.058 BindingDB Entry DOI: 10.7270/Q2JD4WM2 |
More data for this Ligand-Target Pair | |
Matrix metalloproteinase-9
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Universität Bielefeld
Curated by ChEMBL
| Assay Description In vitro inhibition of human matrix metalloprotease-9 |
J Med Chem 44: 3231-43 (2001)
BindingDB Entry DOI: 10.7270/Q2RN3758 |
More data for this Ligand-Target Pair | |
Neutrophil collagenase
(Homo sapiens (Human)) | BDBM50104705
((S)-N-(5-Adamantan-1-yl-6H-[1,3,4]thiadiazin-2-yl)...)Show SMILES C[C@H](NS(=O)(=O)c1ccccc1)C(=O)NC1=NN=C(CS1)C12CC3CC(CC(C3)C1)C2 |r,c:18,t:16,TLB:18:21:24.23.28:26,THB:22:23:26:30.21.29,22:21:24.23.28:26,29:21:24:28.27.26,29:27:24:30.22.21| Show InChI InChI=1S/C22H28N4O3S2/c1-14(26-31(28,29)18-5-3-2-4-6-18)20(27)23-21-25-24-19(13-30-21)22-10-15-7-16(11-22)9-17(8-15)12-22/h2-6,14-17,26H,7-13H2,1H3,(H,23,25,27)/t14-,15?,16?,17?,22?/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| >1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Universität Bielefeld
Curated by ChEMBL
| Assay Description Inhibitory activity against matrix metalloprotease-8 |
J Med Chem 44: 3231-43 (2001)
BindingDB Entry DOI: 10.7270/Q2RN3758 |
More data for this Ligand-Target Pair | |